Explore more publications!

Tech News St. Vincent & Grenadines: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.

Press releases published on November 10, 2025

CareCloud Announces Plan to Pay Double Monthly Dividends on its Series B Preferred Stock Beginning in January 2026
Intermap Announces Date for Third Quarter Earnings
Black Friday just got bigger: Hostinger raises discounts to help everyone start online
Applied Digital Announces Proposed Offering of $2.35 Billion of Senior Secured Notes
IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
AirBoss Defense Group Received Order CBRN Products Valued at $8.1M
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results
Outdoor Holding Company Reports Positive Net Income from Continuing Operations for Second Quarter Fiscal 2026
Immunocore to present at upcoming investor conferences
Editas Medicine Announces Third Quarter 2025 Results and Business Updates
Atana Unveils Organizational Insights to Close Learning Gaps and Reduce Risk Through Strategic Intelligence
Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody
Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results
Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth
HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions